Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 17 of 23, showing 5 Applications out of 114 total, starting on record 81, ending on 85

# Protocol No Study Title Investigator(s) & Site(s)

81.

ECCT/16/09/02   Monitoring Pre-Exposure Prophylaxis for Young Adult Women ( (MPYA)
    Next generation real-time monitoring for PrEP adherence in young adult women.   
Principal Investigator(s)
1. Prof. Elizabeth Anne Bukusi Bukusi
2. Dr. Stella Njuguna Njuguna
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
 
View

82.

ECCT/16/05/02   Monitoring Pre-exposure Prophylaxis for Young Adult women (MPYA)
    Next generation real-time monitoring for PrEP adherence in young Kenyan women   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Partners Study Clinic (Partners in Health Research and Development) (Kiambu county)
2. Partners in Prevention, Kisumu Site (Kisumu county)
 
View

83.

ECCT/16/02/04   comparison of weight adjusted versus fixed dose ondansetron in preventing shivering following spinal anesthesia for cesarean deliveries
    COMPARISON OF WEIGHT ADJUSTED DOSE VERSUS FIXED DOSE ONDANSETRON IN PREVENTING SHIVERING FOLLOWING SPINAL ANESTHESIA FOR CESAREAN DELIVERIES.    
Principal Investigator(s)
1. moses kimuri gicheru KIMURI gicheru
Site(s) in Kenya
AGA kHAN UNIVERSITY HOSPITAL
 
View

84.

ECCT/15/12/01   A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY)
        Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya.   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county)
2. Sirisia, Chwele, Bokoli (Bung\'oma county)
3. Makunga, Mumias (Kakamega county)
 
View

85.

ECCT/15/10/02  
    A non-randomized, open label, single dose, pharmacokinetics, safety and tolerability study of Captopril 50mgs in healthy Kenyan Adults.   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
KEMRI centre for clinical Research
 
View